http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f0f3e1a710dcbe645e0d834ec395f7a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Rebbeck |
| name | Timothy R Rebbeck Timothy R. Rebbeck |
| given-name | Timothy R. Timothy R |
| organization-name | Departments of Biostatistics and Epidemiology at the University; of Pennsylvania School of Medicine; Philadelphia, PA 1Abramson Cancer Center, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; Division of Population Science Dana‐Farber Cancer Institute and Harvard TH Chan School of Public Health Boston Massachusetts USA Department of Biostatistics and Epidemiology and Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Division of Oncology, Children’s Hospital of Philadelphia, Department of Pediatrics, Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Cancer Center, Department of Pathology and Laboratory Medicine, and Center for Cancer Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; Center for Cancer and Blood Disorders, Children’s Medical Center of Dallas, Dallas, TX 75235; and Department of Pediatrics,... 1Departments of Biostatistics and Epidemiology,; 4Center for Clinical Epidemiology and Biostatistics, and; 5Melanoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 8Department of Biostatistics and Epidemiology and Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Dana-Farber Cancer Institute, Boston, MA; Harvard T.H. Chan School of Public Health, Boston, MA Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, USA. Dana‐Farber Cancer Institute and Harvard TH Chan School of Public Health Boston Massachusetts USA Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 5Department of Medical Oncology Dana Farber Cancer Institute, Boston, Massachusetts.; 6Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts. 21Dana-Farber Cancer Institute, Boston, Massachusetts.; 22Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 6Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; 1Dana Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, Massachusetts. 2School of Medicine and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; 18Cancer Epidemiology & Cancer Risk and Disparity, Dana-Farber Cancer Institute, Boston, MA. Author affiliations appear at the end of this article. University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. Julie Lecarpentier, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Goska Leslie, Andrew Lee, Ali Amin Al Olama, Jonathan P. Tyrer, Debra Frost, Steve Ellis, Douglas F. Easton, and Antonis C. Antoniou, University of Cambridge; Karoline B. Kuchenbaecker, The Wellcome Trust Sanger Institute, Hinxton; Marc Tischkowitz, Addenbrooke’s Treatment Centre, Addenbrooke’s Hospital, Cambridge; D. Gareth Evans, Manchester University, Central Manchester University Hospitals NHS Foundation... 33Abramson Cancer Center, University of Pennsylvania School of Medicine; 6Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Division of Population Sciences, Dana Farber Cancer Institute, Boston, MA; Harvard TH Chan School of Public Health, Boston, MA Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA Authors' Affiliations: 1Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, California; 2Center for Biostatistics in AIDS Research, Harvard School of Public Health; 3Department of Medicine, Harvard Medical School and Dana Farber Cancer Institute; 4Beth Israel Deaconess Medical Center, Boston, Massachusetts; 5Abramson Cancer Center, 6Department of Medicine, and 7Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine; 8Fox Chase Cancer Center, Philadelphia, Pennsylvania; 9Division of Special Gynecology, Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria; 10Departments of Medicine, and Preventive Medicine and Public Health, Creighton University, Omaha, Nebraska; 11Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 12Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas; 13Women's College Hospital, Toronto, Onta; Authors' Affiliations: 1Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, California; 2Center for Biostatistics in AIDS Research, Harvard School of Public Health; 3Department of Medicine, Harvard Medical School and Dana Farber Cancer Institute; 4Beth Israel Deaconess Medical Center, Boston, Massachusetts; 5Abramson Cancer Center, 6Department of Medicine, and 7Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine; 8Fox Chase Cancer Center, Philadelphia, Pennsylvania; 9Division of Special Gynecology, Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria; 10Departments of Medicine, and Preventive Medicine and Public Health, Creighton University, Omaha, Nebraska; 11Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 12Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas; 13Women's College Hospital, Toronto, Onta Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Epidemiology and Zhu Family Center for Global Cancer Prevention, Harvard T.H. Chan School of Public Health, Boston, Massachusetts Dana‐Farber Cancer Institute and Brigham and Women's Hospital Boston Massachusetts; Harvard T.H. Chan School of Public Health Boston Massachusetts 5Division of Population Sciences, Dana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, Massachusetts. Department of Radiation Oncology, Dana‐Farber Cancer Institute/Brigham and Women's Hospital Harvard Medical School Boston Massachusetts; Harvard T. H. Chan School of Public Health Boston Massachusetts Medical Oncology, Population Sciences, Dana-Farber/Harvard Cancer Center , Boston, MA, USA 13Division of Hematology and Oncology, Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Authors' Affiliations: 1Center for Clinical Epidemiology and Biostatistics and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; 2The Ohio State University Comprehensive Cancer Center and College of Public Health, Columbus, Ohio; and 3Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida Harvard T.H. Chan School of Public Health, Boston, MA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA Department of Biostatistics and Epidemiology and Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine Philadelphia PA Dana Farber Cancer Institute and Harvard TH Chan School of Public Health Boston Massachusetts USA Center for Genetics and Complex Traits; Department of Biostatistics and Epidemiology; University of Pennsylvania; Philadelphia USA Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. 19Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania. Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA *†From the Abramson Cancer Center, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; *†From the Abramson Cancer Center, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. 1Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology;; 2Abramson Cancer Center, 1School of Medicine and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; Harvard TH Chan School of Public Health and Dana-Farber Cancer Institute, Boston, MA, USA Authors' Affiliations: 1Queensland Institute for Medical Research, Brisbane, Australia; 2Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care; 3Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; 4IARC, Lyon, France; 5University of Pennsylvania School of Medicine; 6Abramson Cancer Center; 7Fox Chase Cancer Center, Philadelphia, Pennsylvania; 8Medical University of Vienna, Waehringer Guertel, Vienna, Austria; 9Hereditary Cancer Risk Program at the Baylor-Sammons Cancer Center; 10University of Texas, Southwestern Medical Center, Dallas, Texas; 11Beth Israel Deaconess Medical Center; 12Dana Farber Cancer Institute, Boston, Massachusetts; 13City of Hope, Duarte; 14UCLA Schools of Medicine and Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, California; 15Creighton University, Omaha, Nebraska; 16Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS; Authors' Affiliations: 1Queensland Institute for Medical Research, Brisbane, Australia; 2Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care; 3Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; 4IARC, Lyon, France; 5University of Pennsylvania School of Medicine; 6Abramson Cancer Center; 7Fox Chase Cancer Center, Philadelphia, Pennsylvania; 8Medical University of Vienna, Waehringer Guertel, Vienna, Austria; 9Hereditary Cancer Risk Program at the Baylor-Sammons Cancer Center; 10University of Texas, Southwestern Medical Center, Dallas, Texas; 11Beth Israel Deaconess Medical Center; 12Dana Farber Cancer Institute, Boston, Massachusetts; 13City of Hope, Duarte; 14UCLA Schools of Medicine and Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, California; 15Creighton University, Omaha, Nebraska; 16Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F.... From the Abramson Family Cancer Research Institute and Departments of Biostatistics and Epidemiology and Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA; Mayo Foundation, Rochester, MN; and Institute of Cancer Research, Sutton, United Kingdom. 12University of Pennsylvania, Philadelphia, Pennsylvania; and 1Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology;; 2Abramson Cancer Center; Dana Farber Cancer Institute and Harvard T.H. Chan School of Public Health Boston Massachusetts USA 1Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, 2Moffitt Cancer Center, Tampa, Florida, and 3University of Pennsylvania, Philadelphia, Pennsylvania Dana–Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA 02215; Authors' Affiliations: 1Department of Biostatistics and Epidemiology and 2Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; Authors' Affiliations: 1Department of Biostatistics and Epidemiology and 2Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania From the University of Michigan School of Medicine; University of Michigan School of Public Health, Ann Arbor, MI; Center for Clinical Epidemiology and Biostatistics and Abramson Family Cancer Research Institute, University of Pennsylvania; University of Pennsylvania School of Medicine, Philadelphia, PA; University of Utah School of Medicine, Salt Lake City, UT; UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ; Lombardi Cancer Center, Georgetown University, Washington, DC; Dana-Farber Cancer... Authors' Affiliation: Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania Authors' Affiliations: Departments of 1Health Studies and 2Medicine, University of Chicago, Chicago, Illinois; 3Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria; 4Department of Epidemiology and Preventive Medicine, University of Maryland, Baltimore, Maryland; Departments of 5Medicine and 6Biostatistics & Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania; 7Karmanos Cancer Institute, Department of Oncology, Wayne State University, Detroit, Michigan; 8Department of Health Research & Policy, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, California; 9Chronic Disease Research Centre and Tropical Medicine Research Institute, University of the West Indies, Bridgetown, Barbados; 10Department of Preventive Medicine, State University of New York at Stony Brook, Stony Brook, New York; and 11Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, Maryland 1Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; Dana Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, MA, USA Department of Epidemiology Harvard University School of Public Health Boston Massachusetts Abramson Cancer Center, Center for Clinical Epidemiology and Biostatistics, and Department of Medicine, The University of Pennsylvania Perleman School of Medicine, Philadelphia, Pennsylvania, USA. rebbeck@upenn.edu Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia 19104-6021, USA. trebbeck@cceb.med.upenn.edu Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, Caroline Andrews, Brian Fortier, Amy Hayward, Ruth Lederman, and Timothy R. Rebbeck; Dana-Farber Cancer Institute; Alex Orfanos and Yuri Quintana, Beth Israel Deaconess Medical Center; Timothy R. Rebbeck, Harvard T.H. Chan School of Public Health, Boston, MA; Lindsay Petersen, Jo McBride, Desiree C. Petersen, Olabode Ajayi, Paidamoyo Kachambwa, Moleboheng Seutloali, Aubrey Shoko, Mamokhosana Mokhosi, and Reinhard Hiller, Centre for Proteomic and Genomic Research; Pedro Fernandez and Hayley Irusen,... Harvard TH Chan School of Public Health and Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Ann M. Nelson, Joint Pathology Center, Silver Spring, MD; Danny A. Milner, Harvard Medical School and Harvard School of Public Health, Boston, MA; Timothy R. Rebbeck, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; and Yawale Iliyasu, Ahmadu Bello University, Zaria, Nigeria. Veronica Wendy Setiawan, Malcolm C. Pike, and Brian E. Henderson, University of Southern California, Los Angeles; James V. Lacey, Jr, and Leslie Bernstein, Beckman Research Institute, City of Hope, Duarte; Hoda Anton-Culver, University of California, Irvine; Pamela L. Horn-Ross, Cancer Prevention Institute of California, Fremont, CA; Hannah P. Yang, Nicolas Wentzensen, Catherine Schairer, Yikyung Park, and Louise A. Brinton, National Cancer Institute, Bethesda, MD; Malcolm C. Pike, Robert A. Soslow,... Authors' Affiliation: Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania Dana‐Farber Cancer Institute/Brigham and Women's Hospital Harvard Medical School Boston Massachusetts; Harvard T.H. Chan School of Public Health Boston Massachusetts 1Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 25Department of Epidemiology and Biostatistics, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadephia, Pennsylvania. 2Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; 4Dana-Farber Cancer Institute. Boston, Massachusetts. 4Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania Center for Clinical Epidemiology and Biostatistics (S.F.B., M.D.S., T.R.R.), Philadelphia, Pennsylvania 19104; Abramson Cancer Center (T.R.R.), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104 2Hematology-Oncology, Department of Medicine,; 3Abramson Cancer Center,; 4Department of Biostatistics and Epidemiology, and Dana Farber Cancer Institute Harvard TH Chan School of Public Health Boston MA USA Authors' Affiliations: 1Center for Clinical Epidemiology and Biostatistics, 2Abramson Cancer Center, and 3Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania; 4Baylor College of Medicine, Houston Texas; 5Clinical Cancer Prevention and 6Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 7College of Public Health and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; and 8Moffitt Cancer Center and Research Institute, Tampa, Florida; Authors' Affiliations: 1Center for Clinical Epidemiology and Biostatistics, 2Abramson Cancer Center, and 3Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania; 4Baylor College of Medicine, Houston Texas; 5Clinical Cancer Prevention and 6Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 7College of Public Health and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; and 8Moffitt Cancer Center and Research Institute, Tampa, Florida Harvard TH Chan School of Public Health and Dana Farber Cancer Institute; Boston USA Authors' Affiliations: 1Department of Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California; 2Mount Sinai School of Medicine, New York; 3University of Pennsylvania, Philiadelphia, Pennsylvania; 4Chao Family Comphrehensive Cancer Center, University of California, Irvine Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 217 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA 116Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; 117Dana-Farber Cancer Institute, Boston, Massachusetts. Center for Population Health and Health Disparities, Univeristy of Pennsylvania, Philadelphia, Pennsylvania, USA. Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, and Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6021, USA. trebbeck@cceb.med.upenn.edu Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts Division of Oncology, Department of Pediatrics, Joseph Stokes, Jr., Research Institute, The Children’s Hospital of Philadelphia, Center for Cancer Pharmacology, Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, Laboratory of Molecular Pharmacology, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health,... From the Department of Biostatistics and Epidemiology; Division of Hematology/Oncology, Department of Medicine; Abramson Cancer Center; Abramson Family Research Institute; and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine; and Division of Hematology/Oncology, Children's Hospital of Philadelphia, Philadelphia, PA Authors' Affiliations: 1Case Comprehensive Cancer Center; 2Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine; 3Division of Hematology and Oncology, University Hospitals Case Medical Center and Case Western Reserve University, Cleveland, Ohio; and 4Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania Authors' Affiliations:1Division of Epidemiology, Department of Environmental Medicine, NYU School of Medicine; 2Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York; 3Division of Urologic Surgery and Department of Genetics, Washington University School of Medicine, St. Louis, Missouri; 4Division of Cancer Prevention and Control, Moffitt Cancer Center, Tampa, Florida; 5Center for Clinical Epidemiology and Biostatistics and Abramson Cancer Center, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; 6Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington; 7Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health; 8Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland; 9Department of Epidemiology, Johns Hopkins Bloom Dana Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, Massachusetts. Division of Population Sciences, Dana Farber Cancer Institute and Department of Epidemiology , Harvard T.H. Chan School of Public Health , Boston, MA 02215 , USA Harvard T.H. Chan School of Public Health Boston Massachusetts USA; Dana‐Farber Cancer Institute Boston Massachusetts USA From the Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics; Department of Psychiatry, Abramson Cancer Center; Department of Medical Ethics; Center for Bioethics, University of Pennsylvania School of Medicine, Philadelphia, PA. Division of Population Sciences, Dana-Farber Cancer Institute and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 17Dana Farber Cancer Institute & Harvard T. H. Chan School of Public Health, Boston, Maryland. Author's Affiliation: 1Department of Biostatistics and Epidemiology and; 2Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania Harvard T.H. Chan School of Public Health and Dana-Farber Cancer Institute, Boston, Massachusetts, USA 8Cancer Epidemiology and Cancer Risk and Disparity, Dana-Farber Cancer Institute, Boston, Massachusetts. Author's Affiliation: Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 1Abramson Cancer Center,; 2Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA University of Pennsylvania 2Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania.; 11Dana Farber Cancer Institute, Boston, Massachusetts. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA Department of Biostatistics and Epidemiology and Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA From the Departments of MedicineBiostatistics and Epidemiology, and Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA, and Department of Surgery, Emory University School of Medicine, Atlanta, GA. Authors' Affiliations: 1Division of Cancer Control and Population Sciences, 2Division of Cancer Epidemiology and Genetics, and 3Division of Cancer Prevention, National Cancer Institute, and 4Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland; 5Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia; 6Stanford Prevention Research Center, Department of Medicine, Department of Health Research and Policy, Stanford University School of Medicine, and Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, California; 7Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas; 8Division of Medicine, Brigham and Women's Hospital; 9Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; 10Department of Epidemiology and Nutrition, Harvard School of Public Health; 11Slone Epidemiology Center, Boston University, Boston, Massachusetts; 12Center for Healt Abramson Cancer Center of the University of Pennsylvania University of Pennsylvania, Philadelphia, Pennsylvania Authors' Affiliations: 1Cancer Prevention and Control Program, Departments of 2Clinical Genetics and 3Surgical Oncology, Urologic Oncology, Fox Chase Cancer Center; and 4Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania; 5Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania From the Cardiovascular Division (E.L., P.D.M., D.D., J.L.S.), Department of Medicine (E.L., P.D.M., D.D., J.L.S., E.W.H.), and Department of Biostatistics and Epidemiology (T.R.R.), Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, Pa. Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania School of Medicine, Philadelphia, 19104, USA. trebbeck@cceb.med.upenn.edu Kosj Yamoah, Robert Den, and Adam P. Dicker, Thomas Jefferson University Hospital; Priti Lal, Michael Feldman, and Timothy R. Rebbeck, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; Kosj Yamoah, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; Michael H. Johnson, Farzana A. Faisal, Ashley E. Ross, and Edward M. Schaeffer, Johns Hopkins University, Baltimore, MD; Voleak Choeurng, Kasra Yousefi, Zaid Haddad, Mohammed Alshalafa, and Elai Davicioni, GenomeDx... Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia2Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Boston, Massachusetts Department of Medical Oncology Dana‐Farber Cancer Institute Boston MA 02215 USA; Department of Epidemiology Harvard TH Chan School of Public Health Boston MA 02115 USA Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 From Thomas Jefferson University, Department of Radiation Oncology and Kimmel Cancer Center; University of Pennsylvania School of Medicine, Department of Epidemiology and Biostatistics, Philadelphia, PA; The Burnham Institute, La Jolla, CA; and Yale University School of Medicine, Departments of Therapeutic Radiology and Pathology, New Haven, CT. Daniel S.W. Tan, National Cancer Centre Singapore and Genome Institute of Singapore, Singapore; Tony S.K. Mok, The Chinese University of Hong Kong, Sir Y. K. Pau Cancer Center, State Key Laboratory of Southern China, Prince of Wales Hospital, Hong Kong, China; and Timothy R. Rebbeck, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. Solomon Tessema Memirie, Timothy R. Rebbeck, and Stéphane Verguet, Harvard T.H. Chan School of Public Health; Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, MA; Mahlet Kifle Habtemariam, Federal Ministry of Health; Mathewos Asefa, Tikur Anbessa Specialized Hospital, Addis Ababa University, Addis Ababa; Biniyam Tefera Deressa, Gondar University, Gondar; Getamesay Abayneh, Haromaya University, Dire Dawa; Biniam Tsegaye, Ayder Comprehensive Specialized Hospital, Mekele University, Mekele; Mihiret... Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts Department of Epidemiology Harvard T.H. Chan School of Public Health Boston Massachusetts USA 3Center for Clinical Epidemiology and Biostatistics, and; 4Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine Philadelphia, PA, USA. 1Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania; 1Center for Clinical Epidemiology and Biostatistics,; 2Abramson Cancer Center, and From the Departments of Biostatistics and Epidemiology, Medicine, and Obstetrics and Gynecology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania; University of Pennsylvania School of Medicine; Abramson Cancer Center; and Children's Hospital of Philadelphia, Philadelphia, PA; and Johnson & Johnson Pharmaceutical Research and Development, Titusville, NJ Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia 19104-6021, USA. trebbeck@cceb.med.upenn.edu Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts; Department of Epidemiology Harvard T.H. Chan School of Public Health Boston Massachusetts From the PROSE Study Group; the Center for Clinical Epidemiology and Biostatistics, Abramson Family Cancer Research Institute, The University of Pennsylvania; and Fox Chase Cancer Center, Philadelphia, PA; Creighton University, Omaha, NE; Division of Genetic Epidemiology, Department of Medicine, University of California Irvine, Irvine, CA; Women’s College Hospital, Toronto, Ontario, Canada; the Netherlands Cancer Institute, Amsterdam, the Netherlands; Dana-Farber Cancer Institute, Boston, MA; St. Mary’s... 3Dana-Farber Cancer Institute and Harvard T. H. Chan School of Public Health, Boston, Massachusetts. Authors' Affiliations: 1Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; 2Department of Preventive Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California; 3The Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, Maryland; 4University of Louisville, Louisville, Kentucky; 5Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan; 6MD Anderson Cancer Center, Houston, Texas; 7Department of Preventive Medicine, University of Southern California, Keck School of Medicine, Los Angeles, California; 8Wake Forest University, Winston-Salem, North Carolina; 9Fox Chase Cancer Center, Philadelphia, Pennsylvania; 10Henry Ford Hospital, Detroit, Michigan; 11Department of Surgery and Genetics, Washington University School of Medicine, St. Louis, Missouri; 12Department of Urology and the Cancer Therapy and Research Center, University of; Authors' Affiliations: 1Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; 2Department of Preventive Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California; 3The Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, Maryland; 4University of Louisville, Louisville, Kentucky; 5Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan; 6MD Anderson Cancer Center, Houston, Texas; 7Department of Preventive Medicine, University of Southern California, Keck School of Medicine, Los Angeles, California; 8Wake Forest University, Winston-Salem, North Carolina; 9Fox Chase Cancer Center, Philadelphia, Pennsylvania; 10Henry Ford Hospital, Detroit, Michigan; 11Department of Surgery and Genetics, Washington University School of Medicine, St. Louis, Missouri; 12Department of Urology and the Cancer Therapy and Research Center, University of University of Pennsylvania, Philadelphia, Pennsylvania. 1Department of Biostatistics and Epidemiology, 9T.H. Chan School of Public Health and Dana Farber Cancer Institute, Harvard University, Boston, Massachusetts. Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. trebbeck@cceb.med.upenn.edu 1Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics and; 2Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 2Center for Clinical Epidemiology & Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania; and Center for Clinical Epidemiology and Biostatistics of the University of Pennsylvania, Philadelphia, PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania Authors' Affiliations: 1Department of Urology, Northwestern University Feinberg School of Medicine; and 2Department of Medicine, University of Illinois, Chicago, Illinois; 3Division of Genetic Epidemiology, University of Utah, Salt Lake City, Utah; 4National Human Genome Research Institute, NIH; and 5Department of Urology and Oncology, Johns Hopkins Medical Institutions, Baltimore, 6Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, and Core Genotyping Facility, SAIC-Frederick, Inc., National Cancer Institute, NIH, DHHS, Gaithersburg; and 7Genome Technology Branch, National Human Genome Research Institute, NIH; and 8Cancer Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland; 9Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; 10Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; and 11The Institute of Cancer Research, Surrey, and T Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania. Department of Epidemiology, Harvard TH Chan School of Public Health, Boston MA Basser Research Centre, Abramson Cancer Center, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA; Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. From the Memorial Sloan-Kettering Cancer Center, New York, NY; Abramson Cancer Center and the Center for Clinical Epidemiology and Biostatistics University of Pennsylvania; Fox Chase Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; Lombardi Comprehensive Cancer Center, Washington, DC; Manchester Regional Genetics Service, Manchester, United Kingdom; Creighton University School of Medicine, Omaha, NE; The Institute of Cancer Research, Sutton, United Kingdom; University of... Harvard T.H. Chan School of Public Health, United States Department of Biostatistics and Epidemiology, University of Pennsylvania; Abramson Family Research Institute, University of Pennsylvania, Philadelphia, PA 4Dana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, Massachusetts. 9School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and Center for Clinical Epidemiology and Biostatistics Perelman School of Medicine at the University of Pennsylvania Philadelphia PA; Abramson Cancer Center Perelman School of Medicine at the University of Pennsylvania Philadelphia PA Dana-Farber Cancer Institute and Harvard T. H. Chan School of Public Health, Boston, MA, USA. 1Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Abramson Cancer Center and |
Incoming Links
Total number of triples: 502.